Address
15, Amazon Street, Maitama District, FCT, Nigeria.
Work Hours
Monday to Friday: 9AM - 5PM
The fight against malaria in Nigeria is set to enter a transformative chapter with the introduction of the malaria vaccine into our routine immunization schedule. The Executive Director of the National Primary Health Care Development Agency (NPHCDA), Dr. Muyi Aina,…
It was an honor for the Women Advocates for Vaccine Access (WAVA) to participate as a CSO representative in Nigeria’s first ever Sector Wide Approach (SWAp) Joint Annual Review (JAR) in the Federal Capital Territory from November 6-8, 2024. Led…
Women Advocates for Vaccine Access (WAVA) in partnership with Direct Consulting and Logistics (DCL), recently hosted Anamaria Bejar, Director of Public Policy Engagement at the Global Alliance for Vaccines and Immunization (GAVI), alongside representatives from Civil Society Organizations (CSOs), youth…
The Government of Nigeria, through the National Primary Healthcare Development Agency (NPHCDA), successfully launched the Human Papillomavirus (HPV) vaccine in 16 phase 1 states in October 2023. The introduction saw a successful turnout. Nigeria met its target coverage rate in…
The National Primary Healthcare Development Agency (NPHCDA), successfully launched the Human Papillomavirus (HPV) vaccine in 16 phase one states in October 2023. The introduction saw a successful turnout, with Nigeria meeting its target coverage rate. This vaccine prevents cervical cancer,…
Are you a young artist with a passion for creativity and a drive to make a positive impact on public health? We invite you to join our HPV Vaccine Art Contest, a platform where your artistic expression can contribute to…
WAVA is supporting the National Primary Healthcare Development Agency (NPHCDA) to introduce the Human Papillomavirus (HPV) Vaccines in Nigeria’s routine immunization schedule by strengthening Civil Society Organizations (CSO) capacity for, and engagement in demand generation to promote HPV vaccine acceptance…
The Government of Nigeria, through the National Primary Health Care Development Agency (NPHCDA), will introduce the Human Papillomavirus vaccine on September 25, 2023. HPV vaccines offer significant value in the prevention of cervical cancer and related diseases. By administering the…
The TM-COVAC study aimed to understand the socio-behavioral drivers and determinants of COVID-19 vaccination to inform targeted communication messaging and implementation strategies and increase vaccination uptake among hesitant HCWs and adults. It was guided by the behavioral and social drivers…
The COVID-19 Vaccine Ethics Research (COVER) project in Nigeria aimed to generate evidence on COVID-19 vaccine misinformation, conspiracies, and acceptance to inform targeted evidence-based messaging and improve COVID-19 vaccine uptake in Nigeria. COVER was a mixed-methods research study conducted in…